South Korea Protein Engineering Market Summary
The South Korea Protein Engineering market is projected to grow significantly from 38 USD Million in 2024 to 147 USD Million by 2035.
Key Market Trends & Highlights
South Korea Protein Engineering Key Trends and Highlights
- The market is expected to experience a compound annual growth rate of 13.09 percent from 2025 to 2035.
- By 2035, the market valuation is anticipated to reach 147 USD Million, indicating robust growth potential.
- In 2024, the market is valued at 38 USD Million, reflecting the current investment landscape in protein engineering.
- Growing adoption of innovative biotechnological solutions due to increasing demand for personalized medicine is a major market driver.
Market Size & Forecast
2024 Market Size | 38 (USD Million) |
2035 Market Size | 147 (USD Million) |
CAGR (2025-2035) | 13.09% |
Major Players
Medytox, Amgen, SK Bioscience, Samsung Biologics, Merck, Roche, Gilead Sciences, Celltrion, Pharming Group, Novo Nordisk, AstraZeneca, LG Chem, Hanmi Pharmaceutical, Green Cross Corporation, Janssen Biotech